BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32561087)

  • 1. CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial.
    Garcia-Botella A; Sáez-Carlin P; Méndez R; Martin MP; Ortega L; Méndez JV; García-Paredes B; Diez-Valladares L; Torres AJ
    Surg Oncol; 2020 Jun; 33():224-230. PubMed ID: 32561087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.
    Deshayes E; Piron L; Bouvier A; Lapuyade B; Lermite E; Vervueren L; Laurent C; Pinaquy JB; Chevallier P; Dohan A; Rode A; Sengel C; Guillot C; Quenet F; Guiu B
    BMC Cancer; 2020 Jun; 20(1):574. PubMed ID: 32560632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.
    am Esch JS; Schmelzle M; Fürst G; Robson SC; Krieg A; Duhme C; Tustas RY; Alexander A; Klein HM; Topp SA; Bode JG; Häussinger D; Eisenberger CF; Knoefel WT
    Ann Surg; 2012 Jan; 255(1):79-85. PubMed ID: 22156926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
    Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
    Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.
    Fürst G; Schulte am Esch J; Poll LW; Hosch SB; Fritz LB; Klein M; Godehardt E; Krieg A; Wecker B; Stoldt V; Stockschläder M; Eisenberger CF; Mödder U; Knoefel WT
    Radiology; 2007 Apr; 243(1):171-9. PubMed ID: 17312278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stem cell-induced liver regeneration].
    Knoefel WT; Alexander A; Tustas RY; Schmelzle M; Klein HM; Krieg A; Topp SA; Eisenberger CF; Fuerst G; Schulte am Esch J
    Zentralbl Chir; 2013 Apr; 138(2):166-72. PubMed ID: 22086774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective portal vein embolization and colorectal liver metastases in rat: a new experimental model for tumor growth study.
    Bretagnol F; Maggiori L; Zappa M; Sibert A; Vilgrain V; Panis Y
    J Surg Res; 2011 Dec; 171(2):669-74. PubMed ID: 20605581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases.
    Robles R; Marín C; Lopez-Conesa A; Capel A; Perez-Flores D; Parrilla P
    Eur J Surg Oncol; 2012 Jul; 38(7):586-93. PubMed ID: 22560404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resection for multiple metastatic liver tumors after preoperative portal embolization].
    Ishizaki Y; Kawasaki S
    Nihon Geka Gakkai Zasshi; 2006 May; 107(3):116-21. PubMed ID: 16734267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal Vein Embolization Followed by Liver Resection versus Liver Resection Alone: a Comparison of Liver Regeneration Dynamics.
    Meyer IA; Vandoni RE; Alerci M; Raptis DA; Gertsch P
    Hepatogastroenterology; 2015 Jun; 62(140):987-91. PubMed ID: 26902042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
    Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
    Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous CD133+ cells augment the effect of portal embolization.
    Canepa MC; Quaretti P; Perotti C; Vercelli A; Rademacher J; Peloso A; Barbieri L; Franchi E; Briani L; Gaspari A; Brugnatelli S; Pedrazzoli P; Dionigi P; Maestri M
    Minerva Chir; 2013 Apr; 68(2):163-8. PubMed ID: 23612229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients.
    Shindoh J; Tzeng CW; Aloia TA; Curley SA; Huang SY; Mahvash A; Gupta S; Wallace MJ; Vauthey JN
    J Gastrointest Surg; 2014 Jan; 18(1):45-51. PubMed ID: 24129824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative portal vein embolization for major liver resection: a meta-analysis.
    Abulkhir A; Limongelli P; Healey AJ; Damrah O; Tait P; Jackson J; Habib N; Jiao LR
    Ann Surg; 2008 Jan; 247(1):49-57. PubMed ID: 18156923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.
    Jaeck D; Oussoultzoglou E; Rosso E; Greget M; Weber JC; Bachellier P
    Ann Surg; 2004 Dec; 240(6):1037-49; discussion 1049-51. PubMed ID: 15570209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.
    Shindoh J; Truty MJ; Aloia TA; Curley SA; Zimmitti G; Huang SY; Mahvash A; Gupta S; Wallace MJ; Vauthey JN
    J Am Coll Surg; 2013 Feb; 216(2):201-9. PubMed ID: 23219349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
    Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
    Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival.
    Elias D; Ouellet JF; De Baère T; Lasser P; Roche A
    Surgery; 2002 Mar; 131(3):294-9. PubMed ID: 11894034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration?
    Hoekstra LT; van Lienden KP; Schaap FG; Chamuleau RA; Bennink RJ; van Gulik TM
    World J Surg; 2012 Dec; 36(12):2901-8. PubMed ID: 22955952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.